글로벌 알로세트론 시장 - 산업 동향 및 2028년까지의 예측

시장 분석 및 통찰력: 글로벌 알로세트론 시장

글로벌 알로세트론 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 위에 언급된 연구 예측 기간 동안 3.50%의 건강한 CAGR로 성장하고 있다고 분석합니다.

알로세트론(일반명: 알로세트론, 상품명: 로트로넥스)은 설사를 주요 문제로 하는 과민성 대장 증후군(IBS)을 가진 여성을 치료하기 위해 처방된 약물입니다. 알로세트론은 5-HT 수용체 길항제 계열에 속합니다. 2번째 위치에 5-메틸-1H-이미다졸-4-일메틸 그룹이 있는 피리도[4,3-b] 인돌 화합물입니다. 세로텐 길항제, 구토제 및 위장약으로 작용합니다. 5-HT3 수용체 길항제의 작용 기전은 구토(구토)를 예방한 다음 화학 요법을 실시하는 것입니다. 미주신경 구심 뉴런의 5-HT3 수용체에서 수용체 길항제는 위장관과 중추 구토계의 5-HT3 수용체의 신경 흥분을 시작하는 5-하이드록시트립타민(5-HT)의 작용을 길항합니다. 복통을 줄이는 역할을 합니다. 알로스테론은 경구 투여 경로로 복용할 수 있습니다. 이 처방은 어린이에게 사용하는 것이 엄격히 권장되지 않습니다. 그러나 알로세트론을 섭취하면 위장 부위가 부어 오르고 치질이 생기고 복통이 생깁니다. 불필요한 약물은 안전한 방법으로 폐기하여 애완동물, 어린아이 및 다른 사람들이 사용하지 않도록 해야 합니다. 로트론은 2000년 2월 식품의약국(FDA)의 승인을 받았습니다.

The rise in cases of irritable bowel syndrome, increased count of women geriatric population, the rise in health expenditure, presence of existing alosetron drugs, increased demand of oral tablets are the factors expected to drive the market growth. However, the presence of strict regulatory protocols, lack of awareness about the symptoms and prevention of irritable bowel syndrome, side effects caused due to consumption of alosetron and lack of sanitation are the restraints which are likely to hinder the market growth. The opportunities which are predicted to propel the market are the emerging markets, rise of untapped opportunities, increasing government and Research and Development activites for production of alosetron drugs and enhancement in healthcare architecture. The reluctance to consume the tablets, use of alternatives, drug recalls and the problems faced in supply chain and logistics for transportation of drugs to the requisite distribution channels are the challenges which are likely to tamper the global Alosetron market.

This Alosetron market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Alosetron Market Scope and Market Size

The Alosetron market is segmented on the basis of dosage type, application, mode of purchase and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of dosage type, the Alosetron market is segmented into 0.5mg, 1mg.
• On the basis of applications, the Alosetron market is segmented into chronic irritable bowel syndrome, visceral pain, gastro intestinal diseases.
• On the basis of mode of purchase, the Alosetron market is segmented into prescription and Over the Counter (OTC).
• On the basis of distribution channel, the Alosetron market is segmented into hospital pharmacies, retail pharmacies, online pharmacies.

Alosetron Market Country Level Analysis

Alosetron market is analysed and market size information is provided by country, dosage type, application, mode of purchase and distribution channel as referenced above.

The countries covered in the Alosetron market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America is expected to hold the largest market share due to the increased availability of alosetron drugs, rising prevalence of patients suffering from irritable bowel syndrome and presence of health policies are predicted to boost the market in the region. The prevalence of irritable bowel syndrome in North America is almost 10-15%. Asia-Pacific is expected to account for the fastest growing market due to upcoming clinics and hospitals, increased awareness about the symptoms of irritable bowel syndrome and safe medication of alosetron and good supply of drugs by the manufacturers.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Alosetron market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Alosetron Market Share Analysis

Alosetron market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Alosetron market.

Alosetron 시장에서 다루는 주요 업체는 Abbott, Allergan, Takeda Pharmaceutical Company Ltd, AstraZeneca, SEBELA PHARMACEUTICALS, SYNERGY PHARMACEUTICALS, Bausch Health Companies Inc, Amneal Pharmaceuticals LLC, ardelyx, Par Pharmaceutical 등 국내 및 글로벌 업체입니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

SKU-60406